
|
 |
 |
 |
News brief: Relatives of boys with sexual birth defects not at risk for testicular germ cell cancer
December 22, 2009
Boys with the sexual birth defects known as hypospadias and cryptorchidism are at risk for developing testicular germ cell cancer, but their relatives are not, according to a new study published online December 21 in the Journal of the National Cancer Institute. Although hypospadias, the birth defect that involves an abnormally-placed urinary opening, and cryptorchidism, the lack of descension of one or both testes in the scrotal sac, are associated with a risk of developing testicular germ cell cancer, it was unclear whether all three were part of an inheritable dysgenesis syndrome.
To study this relationship, Tine H. Schnack, M.D., of the Department of Epidemiology Research, Statens Serum Institute, in Copenhagen, and colleagues identified over 2 million men born since 1953. They were followed from April 1968 through May 2008. First-, second-, and third-degree relatives were identified in the Danish Family Relations Database; cryptorchidism and hypospadias patients were identified in the Danish Hospital Discharge Register; and testicular germ cell cancer patients were identified in the Danish Cancer Register.
Men with a personal history of cryptorchidism or hypospadias had an increased relative risk of developing testicular germ cell cancer, but their relatives did not. A total of 5,441 patients developed testicular germ cell cancer.
The authors write that "-a family history of hypospadias or cryptorchidism was not associated with a general increase in the risk of developing [testicular germ cell cancer]. Thus, our data do not support the hypothesis of shared inheritability of the disorders described under testicular dysgenesis syndrome."
Journal of the National Cancer Institute
|
 |
Related Testicular Germ Current Events and Testicular Germ News Articles Zebrafish journal publishes cancer biology special issue The zebrafish, a translucent fish often used as a model of human development and disease, offers unique advantages for studying the cause, growth, and spread of tumors using strategies and methods presented in the current "Cancer Biology" special issue of Zebrafish.
Second gene linked to familial testicular cancer Specific variations or mutations in a particular can gene raise a man's risk of familial, or inherited, testicular germ-cell cancer, the most common form of this disease.
Cancer rates in teens and early 20s rising - more research needed to understand causes London, UK: A new analysis of cancer figures for England[1] shows that the overall incidence among teenagers and young adults is rising, with the biggest increase among 20 to 24-year-olds, particularly in lymphoma, melanoma and germ cell tumours, including testicular germ cell tumours. A news briefing at Teenage Cancer Trust's Third International Conference on Adolescent Cancer today (Monday 1 March) was told that although cancer is still rare in this age group - around 1,500 cases a year in England - it is the leading cause of death after accidents. Professor Jill Birch, from the University of Manchester, [see note at end of this release] who analysed data for 13 to 24-year-olds between 19 More Testicular Germ Current Events and Testicular Germ News Articles
|
 |
|
|
Testicular Germ Cell Neoplasia: A Developmental Disease?
by Blackwell Munksgaard (Author)
Testicular germ cell cancer is a disease whose incidence in recent decades has ddramatically increased in certain countries around the globe. The possible reasons for this phenomenon were the focus of the 5th Copenhagen Workshop on Carcinoma in situ and Cancer of the Testis. This volume presents the most recent advances in the field of germ cell neoplasia and early gonadal development that were discussed at that meeting.
|

|
Regulation of Sertoli Cell and Germ Cell Differentiation
by Springer
Unwanted childlessness affects approximately one in six couples worldwide. Although the exact proportion of the predominant cause of the problem remains controversial, according to the World Health Organization, in nearly 40 % of cases the cause can be attributed to the female, in 20 % to the male, in 25 % to both, and in 15 % the cause remains unknown. Based on these figures, the incidence of male factor infertility in the general population is approximately 7 %. The majority of these men, approximately 30 %, experience irreversible idiopathic infertility and cannot father children without some form of medical intervention. Male factor infertility, in addition, may be caused by testicular germ cell cancer which is known to represent the most common cancer among young men, aged...
|
|
|
Prediagnostic serum concentrations of organochlorine compounds and risk of testicular germ cell tumors.(Research)(Report): An article from: Environmental Health Perspectives
by Mark P. Purdue (Author), Lawrence S. Engel (Author), Hilde Langseth (Author), Larry L. Needham (Author), Aage Andersen (Author), Dana B. Barr (Author), Aaron Blair (Author), Nathaniel Rothman (Author), Katherine A. McGlynn (Author)
This digital document is an article from Environmental Health Perspectives, published by National Institute of Environmental Health Sciences on October 1, 2009. The length of the article is 8414 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details Title: Prediagnostic serum concentrations of organochlorine compounds and risk of testicular germ cell tumors.(Research)(Report) Author: Mark P. Purdue Publication: Environmental Health Perspectives (Magazine/Journal) Date: October 1, 2009 Publisher: National Institute of Environmental Health Sciences Volume: 117 Issue: 10 Page: 1514(6)
Article Type:...
|

|
Testicular Cancer Research Trends
by Paulo V. Brantus (Editor), Gernot Beutel (Editor), Eugenia Borgione (Editor), Aldo E. Calogero (Editor), Roberto Castiglione (Editor)
Seminomas account for about 30-40 per cent of all testicular tumours. These are usually is found in men in their 30s and 40s. The condition is usually localised to the testes, although in about 25 per cent of cases it has spread to lymph nodes. Non-seminomas account for 60 per cent of all testicular tumours; subcategories of these tumours are listed below.Non-seminoma tumours often contain more than one of the following cell types: Testicular cancer is an abnormal, rapid, and invasive growth of cancerous (malignant) cells in the testicles; Embryonal carcinoma (about 20 per cent of testicular cancers) occurs in 20-30 year olds and is highly malignant - it grows rapidly and spreads to the lung and liver; Yolk sac tumour (about 60 per cent of all testicular cancers in young boys); Teratomata...
|

|
Regulation of Sertoli Cell and Germ Cell Differentiation (Advances in Anatomy, Embryology and Cell Biology)
by R. Brehm (Author), Klaus Steger (Author)
Unwanted childlessness affects approximately one in six couples worldwide. Although the exact proportion of the predominant cause of the problem remains controversial, according to the World Health Organization, in nearly 40 % of cases the cause can be attributed to the female, in 20 % to the male, in 25 % to both, and in 15 % the cause remains unknown. Based on these figures, the incidence of male factor infertility in the general population is approximately 7 %. The majority of these men, approximately 30 %, experience irreversible idiopathic infertility and cannot father children without some form of medical intervention. Male factor infertility, in addition, may be caused by testicular germ cell cancer which is known to represent the most common cancer among young men, aged...
|
|
|
Testicular germ cell tumors (Medical Grand Rounds)
by James F Strauss (Author)
|
|
|
Management of Adult Testicular Germ Cell Tumours: A National Clinical Guideline (SIGN publication)
by Scottish Intercollegiate Guidelines Network (Author)
|
|
|
Epidemiological Studies of Testicular Germ Cell Cancer
by Henrik Moller (Author)
|

|
Germ Cell Tumours V
by Patricia Harnden (Editor), Jonathan K. Joffe (Editor), William G. Jones (Editor)
The International Germ Cell Tumour Conference V brings together the leading clinicians and scientists in the field and covers all aspects of the disease from basic tumour biology, genetics, pathology through to clinical management. This edition will be a valuable reference manual of the proceedings for those involved in treating the disease. As well as including the most up-to-date information on optimum treatment and trial results, this book on the Germ Cell Tumour Conference V provides a forum for the interaction of basic scientists and clinicians to address the current issues. Contributors are at the forefront of research in these important areas. In the search for the optimum trial design in the 21st Century, the book begins with data on DNA repair and malignant cell adaptation to...
|
![Dacarbazine induces genotoxic and cytotoxic germ cell damage with concomitant decrease in testosterone and increase in lactate dehydrogenase concentration ... Toxicology and Environmental Mutagenesis]](http://ecx.images-amazon.com/images/I/51VRJGWFK9L._SX118__PC__PE00_.jpg)
|
Dacarbazine induces genotoxic and cytotoxic germ cell damage with concomitant decrease in testosterone and increase in lactate dehydrogenase concentration ... Toxicology and Environmental Mutagenesis]
by S.G. Kumar (Author), K. Narayana (Author), K.L. Bairy (Author), U.J. D'Souza (Author)
This digital document is a journal article from Mut.Res.-Genetic Toxicology and Environmental Mutagenesis, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.
Description: Treatment of cancers with cytotoxic agents such as alkylating drugs often, but not always results in transient to permanent testicular dysfunction. The present study was planned to investigate the effects of dacarbazine [5-(3,3-dimethyltriazeno) imidazole-4-carboxamide] on testicular function in mice. Swiss albino mice (9-12 weeks old) were treated with 0, 5, 25, 50, or 100mg/kg body weight/day dacarbazine (i.p.) for 5 days at intervals of 24h between treatments. Mice were...
|
|